-
ARVO 2024 Highlight: New Gene Linked to RP in People with African Ancestry
Eye On the Cure Research News -
ARVO 2024 Highlight: Positive Two-Year Results from PDE6B Gene Therapy Clinical Trial
Eye On the Cure Research News
-
Beacon Stories
-
Eye on the Cure Podcast | Episode 65: Matthew Whitaker
Foundation Podcasts -
Atsena’s XLRS Gene Therapy Shows Efficacy in Phase 1/2 Clinical Trial
Eye On the Cure Research News
Our Impact
The Foundation is committed to finding treatments and cures for people affected by blinding retinal diseases.
-
1st gene therapy
for any inherited disease to be approved by the FDA
learn more -
$915M+ dollars raised
since 1971
learn more -
35 VisionWalk events
throughout the United States
learn more -
93 grants awarded
in 2023 – over 96 investigators, 71 institutions
Learn more
The Foundation in the News
ARVO 2024 Highlight: New Gene Linked to RP in People with African Ancestry
Eye On the Cure Research News-
May 10, 2024
ARVO 2024 Highlight: Positive Two-Year Results from PDE6B Gene Therapy Clinical Trial
Eye On the Cure Research News -
May 6, 2024Beacon Stories
-
May 2, 2024
Atsena’s XLRS Gene Therapy Shows Efficacy in Phase 1/2 Clinical Trial
Eye On the Cure Research News
Living with vision loss can be difficult, but you don't have to do it alone
View local chaptersGet Involved
-
Take important steps toward a cure by participating in a 5k VisionWalk
Join a Walk -
Join people coming together to find a cure from all over the country
Search Our Events -
Make a difference today and support promising research by donating a one-time gift
Donate Now